Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT05507632 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05507632
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2026-03-26
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.